ZHEJIANG PEPTITES BIOTECH CO LTD

Overview

ZHEJIANG PEPTITES BIOTECH CO LTD is an active pharmaceutical ingredient (API) supplier with 23 active FDA Type II Drug Master Files, covering 1-METHYLPSEUDOURIDINE-5'-TRIPHOSPHATE TRISODIUM SALT; ANSAMITOCIN P-0; ANSAMITOCIN P-3; CALICHEAMICIN; DERUXTECAN; ETELCALCETIDE HYDROCHLORIDE.

API / Drug Master Files

ZHEJIANG PEPTITES BIOTECH CO LTD holds 23 active (23 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DERUXTECANActive2026-03-31
• LEPTOMYCIN BActive2026-03-30
• CALICHEAMICINActive2026-03-30
• RETATRUTIDEActive2026-01-29
• ETELCALCETIDE HYDROCHLORIDEActive2025-12-30
• SEMAGLUTIDE (PROCESS II)Active2025-12-15
• SEMAGLUTIDE(PROCESS III)Active2025-12-15
• SMCCActive2025-11-28
• TIRZEPATIDEActive2025-11-23
• SEMAGLUTIDEActive2025-07-24
• LINACLOTIDEActive2025-06-08
• VCMMAEActive2024-05-30
• TIRZEPATIDEActive2024-03-17
• PLITIDEPSINActive2023-11-23
• ANSAMITOCIN P-0Active2023-09-25

Showing 15 of 23 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ZHEJIANG PEPTITES BIOTECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.